Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade.
Michal HarelCoren LahavEyal JacobNili DahanItamar SelaYehonatan ElonShani Raveh ShovalGalit YahalomIris KamerAlona ZerOfer SharonDavid P CarboneAdam P DickerJair BarYuval ShakedPublished in: Journal for immunotherapy of cancer (2022)
Our study reveals potential biomarkers in blood plasma for predicting response to ICI therapy in patients with NSCLC and sheds light on mechanisms underlying therapy resistance.